Search Icon

17089-346 NDC - GUNA-PROSTATE (ALDESLEUKIN - BARIUM CARBONATE - CHASTE TREE - CHIMAPHILA UMBELLATA - CLEMATIS VITALBA - CONIUM MACULATUM FLOWERING TOP - DELPHINIUM STAPHISAGRIA SEED - DIGITALIS - FERRIC PICRATE - HUMAN INTERLEUKIN-10 (NONGLYCOSYLATED) - INTERFERON GAMMA-1B - MELATONIN - SAW PALMETTO - SELENIUM - SUS SCROFA PROSTATE - THUJA OCCIDENTALIS TWIG - TRANSFORMING GROWTH FACTOR BETA-1 - ZINC -)

Drug Information

Product NDC: 17089-346

Proprietary Name: GUNA-PROSTATE

Non Proprietary Name: aldesleukin - barium carbonate - chaste tree - chimaphila umbellata - clematis vitalba - conium maculatum flowering top - delphinium staphisagria seed - digitalis - ferric picrate - human interleukin-10 (nonglycosylated) - interferon gamma-1b - melatonin - saw palmetto - selenium - sus scrofa prostate - thuja occidentalis twig - transforming growth factor beta-1 - zinc -

Active Ingredient(s):
  • 4 [hp_C]/30mL ALDESLEUKIN;
  • 30 [hp_X]/30mL BARIUM CARBONATE;
  • 6 [hp_X]/30mL CHASTE TREE;
  • 6 [hp_X]/30mL CHIMAPHILA UMBELLATA;
  • 3 [hp_X]/30mL CLEMATIS RECTA FLOWERING TOP;
  • 30 [hp_X]/30mL CONIUM MACULATUM FLOWERING TOP;
  • 30 [hp_X]/30mL DELPHINIUM STAPHISAGRIA SEED;
  • 30 [hp_X]/30mL DIGITALIS;
  • 30 [hp_X]/30mL FERRIC PICRATE;
  • 4 [hp_C]/30mL INTERFERON GAMMA-1B;
  • 4 [hp_C]/30mL INTERLEUKIN-10;
  • 4 [hp_C]/30mL MELATONIN;
  • 3 [hp_X]/30mL SAW PALMETTO;
  • 30 [hp_X]/30mL SELENIUM;
  • 200 [hp_X]/30mL SUS SCROFA PROSTATE;
  • 30 [hp_X]/30mL THUJA OCCIDENTALIS LEAFY TWIG;
  • 4 [hp_C]/30mL TRANSFORMING GROWTH FACTOR BETA-1;
  • 3 [hp_X]/30mL ZINC


Administration Route(s): ORAL

Dosage Form(s): SOLUTION/ DROPS

Pharmacy Class(es):
  • Increased Lymphocyte Activation [PE];
  • Increased Lymphocyte Cell Production [PE];
  • Interferon gamma [EPC];
  • Interferon-gamma [CS];
  • Interleukin-2 [CS];
  • Iron [CS];
  • Lymphocyte Growth Factor [EPC];
  • Parenteral Iron Replacement [EPC];
  • Phosphate Binder [EPC];
  • Phosphate Chelating Activity [MoA]

Labeler Information

Labeler Name: Guna spa
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:1/1/2017

Package Information

No. Package Code Package Description Billing Unit
117089-346-181 BOTTLE, DROPPER in 1 BOX (17089-346-18) / 30 mL in 1 BOTTLE, DROPPER

NDC Record

Field Name Field Value Definition
PRODUCT NDC17089-346The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEGUNA-PROSTATEThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEaldesleukin - barium carbonate - chaste tree - chimaphila umbellata - clematis vitalba - conium maculatum flowering top - delphinium staphisagria seed - digitalis - ferric picrate - human interleukin-10 (nonglycosylated) - interferon gamma-1b - melatonin - saw palmetto - selenium - sus scrofa prostate - thuja occidentalis twig - transforming growth factor beta-1 - zinc -The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMESOLUTION/ DROPSThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE1/1/2017This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEGuna spaName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEALDESLEUKIN; BARIUM CARBONATE; CHASTE TREE; CHIMAPHILA UMBELLATA; CLEMATIS RECTA FLOWERING TOP; CONIUM MACULATUM FLOWERING TOP; DELPHINIUM STAPHISAGRIA SEED; DIGITALIS; FERRIC PICRATE; INTERFERON GAMMA-1B; INTERLEUKIN-10; MELATONIN; SAW PALMETTO; SELENIUM; SUS SCROFA PROSTATE; THUJA OCCIDENTALIS LEAFY TWIG; TRANSFORMING GROWTH FACTOR BETA-1; ZINCAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH4; 30; 6; 6; 3; 30; 30; 30; 30; 4; 4; 4; 3; 30; 200; 30; 4; 3 
ACTIVE INGRED UNIT[hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_C]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_C]/30mL; [hp_X]/30mL 
PHARM CLASSESIncreased Lymphocyte Activation [PE], Increased Lymphocyte Cell Production [PE], Interferon gamma [EPC], Interferon-gamma [CS], Interleukin-2 [CS], Iron [CS], Lymphocyte Growth Factor [EPC], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023